{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T05:38:57Z","timestamp":1776836337335,"version":"3.51.2"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate the impact of Lineal and Collateral donors on the prognosis of recipients in haplo-HSCT for AA among relatives.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective analysis of data from AA patients who underwent haplo-HSCT at our center from January 2018 to January 2025. Patients were grouped based on the kinship between donors and recipients (Lineal vs. Collateral), and comparisons were made across key indicators, including engraftment, viral reactivation, GVHD, OS, and GRFS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The study included 190 AA patients who received haplo-HSCT. Based on donor type, they were divided into the Lineal group (134 patients) and the Collateral group (56 patients). The results showed that the 3-year OS (92.8% vs. 75.3%,\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a00.004) and 3-year GRFS (78.5% vs. 64.9%,\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a00.062) were relatively higher in the Collateral group compared to the Lineal group. Further analysis revealed that younger donors (age \u2264 40 years) and younger patients (age \u2264 40 years) contributed significantly to improved outcomes in the Collateral group, with both 3-year OS and GRFS being significantly better than in the Lineal group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The study suggests that Collateral donors represent a viable and effective option, particularly in the absence of Lineal donors. The age of the donor and recipient is a critical factor influencing transplantation outcomes, with younger donors and patients potentially enhancing therapeutic efficacy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1727816","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T04:41:24Z","timestamp":1776832884000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["A comparative study of the impact of lineal relatives versus collateral relatives donor on prognosis in haplo-HSCT for aplastic anemia"],"prefix":"10.3389","volume":"17","author":[{"given":"Zhengwei","family":"Tan","sequence":"first","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine);","place":["Hangzhou, China"]},{"name":"The First School of Clinical Medicine, Zhejiang Chinese Medical University;","place":["Hangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ningning","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine);","place":["Hangzhou, China"]},{"name":"The First School of Clinical Medicine, Zhejiang Chinese Medical University;","place":["Hangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuechao","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine);","place":["Hangzhou, China"]},{"name":"The First School of Clinical Medicine, Zhejiang Chinese Medical University;","place":["Hangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huijin","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine);","place":["Hangzhou, China"]},{"name":"The First School of Clinical Medicine, Zhejiang Chinese Medical University;","place":["Hangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinghong","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine);","place":["Hangzhou, China"]},{"name":"The First School of Clinical Medicine, Zhejiang Chinese Medical University;","place":["Hangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine);","place":["Hangzhou, China"]},{"name":"The First School of Clinical Medicine, Zhejiang Chinese Medical University;","place":["Hangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tonglin","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine);","place":["Hangzhou, China"]},{"name":"The First School of Clinical Medicine, Zhejiang Chinese Medical University;","place":["Hangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dijiong","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine);","place":["Hangzhou, China"]},{"name":"The First School of Clinical Medicine, Zhejiang Chinese Medical University;","place":["Hangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baodong","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine);","place":["Hangzhou, China"]},{"name":"The First School of Clinical Medicine, Zhejiang Chinese Medical University;","place":["Hangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenbin","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine);","place":["Hangzhou, China"]},{"name":"The First School of Clinical Medicine, Zhejiang Chinese Medical University;","place":["Hangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-08-693481","article-title":"How I treat acquired aplastic anemia","volume":"129","author":"Bacigalupo","year":"2017","journal-title":"Blood"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021004345","article-title":"Approach to the diagnosis of aplastic anemia","volume":"5","author":"DeZern","year":"2021","journal-title":"Blood Adv"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018021162","article-title":"Severe aplastic anemia: allogeneic bone marrow transplantation as first-line treatment","volume":"2","author":"Georges","year":"2018","journal-title":"Blood Adv"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000001106","article-title":"Allogeneic matched related donor bone marrow transplantation for pediatric patients with severe aplastic anemia using \u2018low-dose\u2019 cyclophosphamide, ATG plus fludarabine","volume":"40","author":"Takpradit","year":"2018","journal-title":"J Pediatr Hematol Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1142\/9789812565822_0040","article-title":"Hematopoietic stem cell transplantation and immunosuppressive therapy: implications of clonal hematopoiesis","volume":"104","author":"Tan","year":"2025","journal-title":"Ann Hematol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-02-767731","article-title":"Origins of myelodysplastic syndromes after aplastic anemia","volume":"130","author":"Negoro","year":"2017","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1037.e1","DOI":"10.1016\/j.jtct.2025.09.014","article-title":"Haploidentical vs. Matched sibling donor HCT in racially diverse pediatric and AYA patients with hematologic Malignancies: a single-center comparison","volume":"31","author":"Filioglou","year":"2025","journal-title":"Transplant Cell Ther"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024024173","article-title":"Alternative donor transplantation for severe aplastic anemia: a comparative study of the SAAWP EBMT","volume":"144","author":"Montoro","year":"2024","journal-title":"Blood"},{"key":"B9","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41409-019-0499-z","article-title":"The european society for blood and marrow transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell transplantation","volume":"55","author":"Ciurea","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"B10","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13045-019-0775-9","article-title":"Who is the best haploidentical donor for acquired severe aplastic anemia? Experience from a multicenter study","volume":"12","author":"Xu","year":"2019","journal-title":"J Hematol Oncol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13045-023-01421-9","article-title":"Similar outcomes following non-first-degree and first-degree related donor haploidentical hematopoietic cell transplantation for acute leukemia patients in complete remission: a study from the global committee and the acute leukemia working party of the european society for blood and marrow transplantation","volume":"16","author":"Ye","year":"2023","journal-title":"J Hematol Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024014858","article-title":"Transplant outcomes using older matched sibling donors compared with young alternative donors: a CIBMTR analysis","volume":"9","author":"Nath","year":"2025","journal-title":"Blood Adv"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.19236","article-title":"Guidelines for the diagnosis and management of adult aplastic anemia: a British society for hematology guideline","volume":"204","author":"Kulasekararaj","year":"2024","journal-title":"Br J Hematol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2025.12.942","article-title":"Novel FABT-based conditioning regimen with haploidentical transplantation for severe aplastic anemia: a prospective, single-center, phase II clinical trial","author":"Liu","year":"2026","journal-title":"Transplant Cell Ther"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 diagnosis and staging working group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-10-609032","article-title":"Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation","volume":"125","author":"Holtan","year":"2015","journal-title":"Blood"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.13829","article-title":"Treatment of severe aplastic anemia with a combination of horse antithymocyte globulin and cyclosporine, with or without sirolimus: a prospective randomized study","volume":"94","author":"Scheinberg","year":"2009","journal-title":"Hematologica"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2013.224","article-title":"Long-term outcome of HLA-haploidentical hematopoietic SCT without in vitro T-cell depletion for adult severe aplastic anemia after modified conditioning and supportive therapy","volume":"49","author":"Gao","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2019.106266","article-title":"Comparison of frontline treatment with intensive immunosuppression therapy and HLA-haploidentical hematopoietic stem cell transplantation for young patients with severe aplastic anemia - a meta-analysis","volume":"88","author":"Geng","year":"2020","journal-title":"Leuk Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2023.12.317","article-title":"Young (<35 years) haploidentical versus old (\u226535 years) mismatched unrelated donors and vice versa for allogeneic stem cell transplantation with post-transplant cyclophosphamide in patients with acute myeloid leukemia in first remission: a study on behalf of the acute leukemia working party of the european society for blood and marrow transplantation","volume":"59","author":"Nagler","year":"2024","journal-title":"Bone Marrow Transplant"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-023-01984-8","article-title":"Impact of donor age and relationship on outcomes of peripheral blood haploidentical hematopoietic cell transplantation","volume":"58","author":"Pruitt","year":"2023","journal-title":"Bone Marrow Transplant"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701923","article-title":"Telomere length changes in patients undergoing hematopoietic stem cell transplantation","volume":"24","author":"Lee","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(05)66879-1","article-title":"Telomerase activation and rejuvenation of telomere length in stimulated T cells derived from serially transplanted hematopoietic stem cells","volume":"196","author":"Allsopp","year":"2002","journal-title":"J Exp Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.674093","article-title":"Immune reconstitution in the aging host: opportunities for mechanism-based therapy in allogeneic hematopoietic cell transplantation","volume":"12","author":"Lin","year":"2021","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/s41392-024-02005-w","article-title":"Comprehensive snapshots of natural killer cells functions, signaling, molecular mechanisms and clinical utilization","volume":"9","author":"Chen","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B26","doi-asserted-by":"publisher","first-page":"6138","DOI":"10.1038\/s41598-017-06238-4","article-title":"CD56 is a pathogen recognition receptor on human natural killer cells","volume":"7","author":"Ziegler","year":"2017","journal-title":"Sci Rep"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2012.03.036","article-title":"Role of killer immunoglobulin-like receptor-ligand interactions in human leukocyte antigen-matched sibling hematopoietic stem cell transplantation","volume":"44","author":"Kanga","year":"2012","journal-title":"Transplant Proc"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.821533","article-title":"KIR in allogeneic hematopoietic stem cell transplantation: need for a unified paradigm for donor selection","volume":"13","author":"Dhuyser","year":"2022","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/ejh.70039","article-title":"Toll-like receptor polymorphisms influence graft-versus-host disease and infection risk after single-unit cord blood transplantation for adults","volume":"116","author":"Konuma","year":"2026","journal-title":"Eur J Hematol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s00281-024-01028-3","article-title":"Clinical relevance of feto-maternal microchimerism in (hematopoietic stem cell) transplantation","volume":"47","author":"Kruchen","year":"2024","journal-title":"Semin Immunopathol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1097\/MOP.0000000000000087","article-title":"Maternal-fetal cellular trafficking: clinical implications and consequences","volume":"26","author":"Jeanty","year":"2014","journal-title":"Curr Opin Pediatr"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.966301","article-title":"Decoupling blood telomere length from age in recipients of allogeneic hematopoietic cell transplant in the BMT-CTN 1202","volume":"13","author":"Lai","year":"2022","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1727816\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T04:41:29Z","timestamp":1776832889000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1727816\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":32,"alternative-id":["10.3389\/fimmu.2026.1727816"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1727816","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"article-number":"1727816"}}